on NanoViricides, Inc. (NASDAQ:NNVC)
NanoViricides Presents at Spartan Capital Investors Conference 2024
NanoViricides, Inc., a clinical-stage company specializing in antiviral nanomedicines, is participating in the Spartan Capital Investors Conference 2024. Dr. Anil R. Diwan, President and Executive Chairman, is delivering a corporate update at the event. The conference takes place at the Pierre Hotel in New York City.
A key focus of the presentation is NV-387, a broad-spectrum antiviral drug candidate. NV-387 has completed Phase I trials and shown promising results in animal models for diseases like Influenza, RSV, and COVID-19. The potential market for these treatments could reach over $10 billion by 2027.
The conference is a platform for over 30 companies, offering presentations, panel discussions, and networking opportunities to foster interactions between investors and presenters.
R. P.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all NanoViricides, Inc. news